The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First interim analysis of a phase 1 study of zanubrutinib (zanu) plus lenalidomide (len) in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
 
Huilai Zhang
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Haiyan Yang
No Relationships to Disclose
 
Liling Zhang
No Relationships to Disclose
 
Liqun Zou
No Relationships to Disclose
 
Ye Guo
Honoraria - BMS; Merck Serono; MSD; Roche
Consulting or Advisory Role - Bayer; Merck Serono; MSD; Roche
 
Junning Cao
No Relationships to Disclose
 
Huiqiang Huang
No Relationships to Disclose
 
Zhao Wang
No Relationships to Disclose
 
Sha Huang
Employment - BeiGene Shanghai
Stock and Other Ownership Interests - BeiGene
 
Zhiyu Liang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Jiaoyan Lyu
No Relationships to Disclose
 
Yiqian Fang
No Relationships to Disclose
 
Aileen Cohen
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Keshu Zhou
No Relationships to Disclose